Skip to main content

Articles

Page 10 of 10

  1. Chloroquine (CQ), after 67 years of use in Haiti, is still part of the official treatment policy for malaria. Several countries around the world have used CQ in the past due to its low incidence of adverse eve...

    Authors: Michael E von Fricken, Thomas A Weppelmann, Jennifer D Hosford, Alexander Existe and Bernard A Okech

    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:10

    Content type: Review

    Published on:

  2. Antibacterial drugs (hereafter referred to as antibiotics) are crucial to treat infections during delivery and postpartum period to reduce maternal mortality. Institutional deliveries have the potential to sav...

    Authors: Megha Sharma, Linda Sanneving, Kalpana Mahadik, Michele Santacatterina, Suryaprakash Dhaneria and Cecilia Stålsby Lundborg

    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:9

    Content type: Research

    Published on:

  3. Continuous provision of appropriate medicines of assured quality, in adequate quantities, and at reasonable prices is a concern for all national governments. A national medicines policy (NMP) developed in a co...

    Authors: Joëlle M Hoebert, Liset van Dijk, Aukje K Mantel-Teeuwisse, Hubert GM Leufkens and Richard O Laing

    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:5

    Content type: Review

    Published on:

  4. Bacterial meningitis is a medical emergency associated with high mortality rates. Cerebrospinal fluid (CSF) culture is the “gold standard” for diagnosis of meningitis and it is important to establish the susce...

    Authors: Assegid Mengistu, Johannes Gaeseb, Gottfried Uaaka, Christophine Ndjavera, Kennedy Kambyambya, Lazarus Indongo, Francis Kalemeera, Christopher Ntege, David Mabirizi, Mohan P Joshi and Evans Sagwa

    Citation: Journal of Pharmaceutical Policy and Practice 2013 6:4

    Content type: Research

    Published on:

Annual Journal Metrics